Stay updated with breaking news from Abbott Media. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Abbott (NYSE: ABT) today announced that the U.S. Food and Drug Administration (FDA) has approved the Esprit™ BTK Everolimus Eluting Resorbable Scaffold System (Esprit BTK System), a breakthrough innovation for people with chronic limb-threatening ischemia (CLTI) below-the-knee (BTK). The Esprit BTK System is ...
New Study Shows Mixed Reality Technology for Blood Donation From Abbott ...
Diana Isaacs, PharmD, and Natalie Bellini, DNP, provide a breakdown of the latest news in diabetes management, including FDA clearance of a new insulin pump and a major acquisition within the diabetes world.
Abbott, Real Madrid and the Real Madrid Foundation launch 'Beat Malnutrition' campaign as part of a sustained collaboration urging communities to work together to reduce malnutritionCampaign will supply
AbbottNew efforts focus on research infrastructure, continued training of diverse clinical research personnel and improved diversity within Abbott's own clinical trialsAbbott's Diversity in Clinical Trials